Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,961 to 1,980 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice. | PLoS One | 2018 | 30188931 | PubTator, text mining | PubMed |
| Spinal muscular atrophy within Amish and Mennonite populations: Ancestral haplotypes and natural history. | PLoS One | 2018 | 30188899 | PubTator, text mining | PubMed |
| Functional Connectivity Alterations in Children with Spastic and Dyskinetic Cerebral Palsy. | Neural Plast | 2018 | 30186320 | PubTator, text mining | PubMed |
| [Pharmacological and clinical profile of spinal muscular atrophy (SMA) therapeutic drug nusinersen (Spinraza®)]. | Nihon Yakurigaku Zasshi | 2018 | 30185733 | PubTator, text mining | PubMed |
| Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer. | Mol Cancer Ther | 2018 | 30181330 | PubTator, text mining | PubMed |
| An orthogonal proteomic survey uncovers novel Zika virus host factors. | Nature | 2018 | 30177828 | PubTator, text mining | PubMed |
| Quantitative Activity Profile and Context Dependence of All Human 5' Splice Sites. | Mol Cell | 2018 | 30174293 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy. | Methods Mol Biol | 2018 | 30171558 | PubTator, text mining | PubMed |
| Pre-mRNA Splicing Modulation by Antisense Oligonucleotides. | Methods Mol Biol | 2018 | 30171557 | PubTator, text mining | PubMed |
| Nusinersen in the Treatment of Spinal Muscular Atrophy. | Methods Mol Biol | 2018 | 30171535 | PubTator, text mining | PubMed |
| Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy. | Methods Mol Biol | 2018 | 30171534 | PubTator, text mining | PubMed |
| High-affinity RNA targets of the Survival Motor Neuron protein reveal diverse preferences for sequence and structural motifs. | Nucleic Acids Res | 2018 | 30165668 | PubTator, text mining | PubMed |
| Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study. | Neurology | 2018 | 30158155 | PubTator, text mining | PubMed |
| Lafora disease - from pathogenesis to treatment strategies. | Nat Rev Neurol | 2018 | 30143794 | PubTator, text mining | PubMed |
| Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy. | J Pediatr Orthop | 2018 | 30134351 | PubTator, text mining | PubMed |
| Drosophila as a Model for Assessing the Function of RNA-Binding Proteins during Neurogenesis and Neurological Disease. | J Dev Biol | 2018 | 30126171 | PubTator, text mining | PubMed |
| Homozygous mutation in the Neurofascin gene affecting the glial isoform of Neurofascin causes severe neurodevelopment disorder with hypotonia, amimia and areflexia. | Hum Mol Genet | 2018 | 30124836 | PubTator, text mining | PubMed |
| Current Therapeutic Approaches in Leukodystrophies: A Review. | J Child Neurol | 2018 | 30112967 | PubTator, text mining | PubMed |
| A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein. | PLoS One | 2018 | 30102724 | PubTator, text mining | PubMed |
| RNA Therapeutics in Cardiovascular Precision Medicine. | Front Physiol | 2018 | 30090066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=99